Hearing screening of neonates born to women who were positive SARS-CoV-2 PCR during pregnancy Automated auditory brainstem response (ABR) Otoacoustic emission (OAE) Newborn hearing screening COVID-19 SARs-CoV-2 Vertical transmission
Conditions
Interventions
Neonates born to women who were positive SARS-CoV-2 PCR during pregnancy in King Chulalongkorn Memorial Hospital ,Neonates born to healthy women in King Chulalongkorn Memorial Hospital
Screening,Screening
Neonates of COVID19 infected mothers,Neonates of healthy mothers
Sponsors
None listed
Eligibility
Sex/Gender
All
Age
48 Hours to No maximum
Inclusion criteria
Inclusion criteria: 1. Neonates born to mothers who were positive SARS-CoV-2 PCR during pregnancy or neonates born to healthy women 2. Neonates with normal ear canal 3. Singleton
Exclusion criteria
Exclusion criteria: 1. Family of childhood hearing loss 2. Admitted in neonatal intensive care more than 5 days 3. Hyperbilirubinemia with exchange transfusion 4. Aminoglycoside administration for more than 5 days, 5. Asphyxia or hypoxic ischemic encephalopathy, extracorporeal membrane oxygenation (ECMO) 6. In utero infections of toxoplasmosis, rubella, cytomegalovirus, herpes, syphilis,Zika 7. Craniofacial malformation 8. Syndrome associated with hearing loss 9. Culture-positive infection associated with sensorineural hearing loss 10. Major birth head injury to skull (for example Skull fracture) 11. Small for gestational age (SGA) 12. Neonatal seizure 13. Positive PCR for SARS-CoV-2 neonates
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| newborn hearing screening after 48 hours of birth TEOAE, ABR | — |
Secondary
| Measure | Time frame |
|---|---|
| n/a n/a n/a | — |
Countries
Thailand
Contacts
Public ContactSupaksarun cheewasukanont
Faculty of medicine, Chulalongkorn University
Outcome results
None listed